Kiniksa (KNSA) Director Cole G Bradley Sells Shares

What Happened

• Cole G Bradley, a director of Kiniksa Pharmaceuticals International, sold 3,673 shares in an open-market/private sale on July 29, 2026 at $81.43 per share, generating proceeds of approximately $299,092. On the same date he also disposed of 4,500 shares as a gift (no proceeds reported).
• The gift transaction is reported as a bona fide donation to a donor-advised fund (see footnote F1). Sales are often routine insider activity; gifts do not necessarily indicate the insider’s view of the company.

Key Details

• Transaction date: July 29, 2026. Filing date (Form 4): July 31, 2026 (appears filed within the usual two-business-day window).
• Sale: 3,673 shares at $81.43 — proceeds ≈ $299,092.
• Gift: 4,500 shares at $0.00 — footnote F1: bona fide gift to a donor-advised fund.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• No 10b5-1 plan, tax withholding, option exercise, or late-filing flag noted in the provided information.

Context

• Sales remove shares from the insider’s holdings and are often personal or portfolio-management actions rather than a clear signal about company prospects. Gifts to donor-advised funds are philanthropic and likewise do not imply market sentiment.
• For retail investors, purchases by insiders can be more informative than routine sales; this filing shows a sale plus a charitable transfer, not an acquisition.